Stanisław Burzyński

From Wikipedia, the free encyclopedia

Stanisław Rajmund Burzyński (born 1943 in Lublin, Poland), MD, PhD, is a Polish biochemist and physician, the discoverer of Antineoplastons.

Stanislaw R. Burzynski, MD, PhD, is a physician and biochemist-researcher who pioneered the development and use of biologically active peptides in diagnosing, preventing and treating cancer since 1967.

Dr. Burzynski's unconventional treatment has not been scientifically verified. After decades his "antineoplaston" therapy is still being tested in clinical trials and has not been approved by the Food and Drug Administration. Dr. Burzynski was brought to court in Texas in 1997 for making fraudulent claims and in 1998 the Texas attorney General placed limits on his advertising of antineoplastins. See http://www.quackwatch.org/04ConsumerEducation/News/burzynski.html for more information.

In 1967, at the young age of 24, S.R. Burzynski graduated from the Medical Academy in Lublin, Poland, with a M.D. degree with distinction, finishing first in his class of 250. During the same year he identified naturally occurring peptides in the human body which he concluded control cancer growth. He found that there is a marked deficiency of these peptides in cancer patients.

The following year, 1968, he earned his Ph.D. in Biochemistry as one of the youngest candidates in Poland ever to hold both an M.D. and Ph.D.

From 1970 to 1977, while a researcher and Assistant Professor at Baylor College of Medicine in Houston, his research was sponsored and partially funded by the National Cancer Institute. At Baylor, he authored and co-authored 16 publications, including 5 concerning his research on peptides and their effect on human cancer. Four of these publications were also co-authored by other doctors associated with M.D. Anderson Hospital and Tumor Institute, and Baylor College of Medicine. It was at Baylor that Dr. Burzynski named these peptides Antineoplastons due to their activity in correcting and normalizing neoplastic, or cancerous, cells.

In May 1977, Dr. Burzynski received a Certificate of Appreciation from Baylor College of Medicine, commending him for completing five years of dedicated service and acknowledging his contributions made to the “Advancement of Medical Education, Research, and Health Care”.

In May 1977 Dr. Burzynski founded his clinic in Houston where he's since treated over 8,000 patients. He is also the president of the Burzynski Research Institute [1], where he continues to pursue scientific research on Antineoplastons.

Dr. Burzynski is a member in good standing of renowned medical associations, including the American Medical Association, World Medical Association, American Association for Cancer Research, Society for Neuroscience, Texas Medical Association, Royal Medical Association, Academy of Medical Ethics, Society for Neuro-Oncology, and many others.

Dr. Burzynski is the author and co-author of more than 250 scientific publications, including over 90 about Antineoplastons, presenter of scientific papers at major international medical conventions and recipient of numerous prestigious awards. Currently dr. Burzynski holds 212 patents and 28 trademarks in 35 countries for his treatments and inventions (data as of January 2007).

Other groups of scientists have replicated and expanded Dr. Burzynski's work, including researchers at the National Cancer Institute, the Medical College of Georgia, the Imperial College of Science and Technology of London, the University of Kurume Medical School in Japan, the University of Turin Medical School in Italy, and many others. There are several hundred publications on Antineoplastons and their active ingredients written by scientists working independently of the Burzynski Research Institute.